Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease.
Transl Res. 2015 Dec;166(6):783-7. doi: 10.1016/j.trsl.2015.04.010. Epub 2015 Apr 27.
Transl Res. 2015.
PMID: 26001593
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging.
García-Saenz JA, Ayllón P, Laig M, Acosta-Eyzaguirre D, García-Esquinas M, Montes M, Sanz J, Barquín M, Moreno F, Garcia-Barberan V, Díaz-Rubio E, Caldes T, Romero A.
García-Saenz JA, et al. Among authors: acosta eyzaguirre d.
BMC Cancer. 2017 Mar 22;17(1):210. doi: 10.1186/s12885-017-3185-9.
BMC Cancer. 2017.
PMID: 28330468
Free PMC article.
Item in Clipboard
Experience with eribulin in patients with metastatic breast cancer and associated hepatic impairment: case studies.
Acosta-Eyzaguirre D, Calvo Plaza I, Perelló Martorell A, Hernández Agudo E, García-Estévez L.
Acosta-Eyzaguirre D, et al.
Future Oncol. 2018 Mar;14(7s):29-36. doi: 10.2217/fon-2017-0358.
Future Oncol. 2018.
PMID: 29611757
Item in Clipboard
Cite
Cite